The anemia prevalence and the association between complete blood count analysis and renal function parameters in HIV-1-infected patients

Current HIV Research

Volumn 10, Issue 3, 2012, Pages 247-251

  Dabrowska, Magdalena M ^a   Mikula, Tomasz ^a   Wiercinska Drapalo, Alicja ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Anemia; Chronic kidney disease; Complete blood count analysis; eGFR; HIV; Thrombocytopenia

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ERYTHROCYTE COUNT; FEMALE; GLOMERULUS FILTRATION RATE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; POLAND; PREVALENCE; THROMBOCYTE COUNT;

EID: 84861133138     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016212800618147     Document Type: Article

References (24)

1. Renal Data Systems. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009.
2. Fulop T, Olivier J, Meador RS, et al. Screening for chronic kidney disease in the ambulatory HIV population. Clin Nephrol 2010; 73: 190-6.
3. Choi AI, Shlipak MG, Hunt PW, Martin JN, Deeks SG. HIVinfected persons continue to lose kidney function despite successful antiretroviral therapy. AIDS 2009; 23: 2143-9.
4. Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med 2009; 10: 329-36.
5. Déti EK, Thiébaut R, Bonnet F, et al. Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France. HIV Med 2010; 11: 308-17.
6. Bansi L, Hughes A, Bhagani S, et al. Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS 2009; 23: 2517-21.
7. Crum-Cianflone N, Ganesan A, Teneza-Mora N, et al. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS Patient Care STDS 2010; 24: 353-60.
8. Firnhaber C, Smeaton L, Saukila N, et al. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. Int J Infect Dis 2010; 14: e1088-92.
9. Subbaraman R, Devaleenal B, Selvamuthu P, et al. Factors associated with anaemia in HIV-infected individuals in southern India. Int J STD AIDS 2009; 20: 489-92.
10. Jam S, Ramezani A, Sabzvari D, et al. A cross-sectional study of anemia in human immunodeficiency virus-infected patients in Iran. Arch Iran Med. 2009; 12: 145-50.
11. Mata-Marín JA, Gaytán-Martínez JE, Martínez-Martínez RE, Arroyo-Anduiza CI, Fuentes-Allen JL, Casarrubias-Ramirez M. Risk factors and correlates for anemia in HIV treatment-naïve infected patients: a cross-sectional analytical study. BMC Res Notes 2010; 3: 230.
12. Serpa JA, Villarreal-Williams E, Giordano TP. Prevalence of G6PD deficiency in a large cohort of HIV-infected patients. J Infect 2010; 61: 399-402.
13. Mehta S, Giovannucci E, Mugusi FM, et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One 2010; 5: e8770.
14. Tsiakalos A, Kordossis T, Ziakas PD, Kontos AN, Kyriaki D, Sipsas NV. Circulating antibodies to endogenous erythropoietin and risk for HIV-1-related anemia. J Infect 2010; 60: 238-43.
15. The European Guidelines for treatment of HIV infected adults in Europe. Available at: http://www.europeanaidsclinicalsociety.org/guidelines.asp.
16. QxMD Online Calculator. Available at: http://qxmd.com/renal/Calculate-MDRD-GFR.php.
17. QxMD Online Calculator. Available at: http://www.qxmd.com/renal/Calculate-CKD-EPI-GFR.php.
18. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40: 1559-85.
19. Mildvan D, Creagh T, Leitz G, et al. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study. Curr Med Res Opin 2007; 23: 343-55.
20. Levine AM, Berhane K, Masri-Lavine L, et al. Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2001; 26: 28-35.
21. Semba RD, Shah N, Klein RS, et al. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis 2002; 34: 260-6.
22. Volberding PA, Levine AM, Dieterich D, et al. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis 2004; 38: 1454-63.
23. Kalayjian RC, Franceschini N, Gupta SK, et al. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS 2008; 22: 481-7.
24. Atta MG, Gallant JE, Rahman MH, et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 2006; 21: 2809-13.